Catch up on the clinical trial news, updates from the United States Food and Drug Administration (FDA), and company funding ...

The company also released additional data from its phase 2 clinical trial in addition to the LONGITUDE program design.

The campaign will spotlight educational resources and share stories of individuals and families living with glaucoma to raise ...

Oxular began a phase 2 trial for its therapeutic candidate OXU-001, for the treatment of diabetic macular edema in October ...

Himani Goyal, MD, assesses the benefits of proactive glaucoma management through interventional procedures beyond traditional treatments, focusing on treatment customization based on factors such as ...

These resources include downloadable fact sheets, glaucoma financial assistance resources, shareable social media graphics, ...

The primary safety endpoint was carried out through the percentage of patients with shift from normal (at baseline) to ...

The rationale was that commercial mydriatics administered during retinopathy of prematurity (ROP) screening have been ...

Patients with fibromyalgia experienced changes in the macular ganglion cell layer and retinal nerve fiber layer.

ArMaDa clinical trial is set to assess the safety and efficacy of unilateral subretinal administration of OCU410 in subjects with GA ...

The multinational, multicenter, prospective RESTORE Study is the 5-year follow-up study of the phase 3 clinical RESCUE and ...